PPARGC1A and diabetic kidney disease: Our study suggests that TBN improves mitochondrial dysfunction and suppresses oxidative stress to slow the progression of DKD, possibly through upregulation of AMPK/PGC-1α-mediated downstream signaling pathways (Figure 8).